Skip to main content
Premium Trial:

Request an Annual Quote

Sionex Joins Boston Integrative Medicine Group

NEW YORK, Nov. 10 (GenomeWeb News) - Sionex, a developer of chemical and biological sensor chips and systems, has joined the Center for Integration of Medicine and Innovative Technology.

 

The center brings together scientists, engineers, and clinicians in the Boston area to develop new technologies with an emphasis on minimially invasive diagnostics and therapy. CIMIT has a center at HarvardMedicalSchool composed of experts from Massachusetts GeneralHospital, Brigham and Women's Hospital, the Massachusetts Institute of Technology, among others.

 

Waltham, Mass.-based Sionex has developed microDMX sensors and is applying the technology to detection of explosive, narcotic, and chemical compounds, and is aiming to utilize the technology in biopharmaceuticals and diagnostics.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.